| LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112.0 days
| 11 |
10.1 |
mg/100g |
0.2 |
0.66 |
post excision weight measurement |
0.0 |
|
102690 |
2703 |
| LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112.0 days
| 7 |
12.5 |
mg/100g |
0.5 |
1.32 |
post excision weight measurement |
0.0 |
|
102691 |
2703 |
| LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
aorta mass |
male |
112.0 days
| 14 |
13.1 |
mg/100g |
0.1 |
0.37 |
post excision weight measurement |
0.0 |
|
102773 |
2721 |
| LH/Mav |
aorta weight to body weight ratio |
controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
aorta mass |
male |
119.0 days
| 7 |
13.3 |
mg/100g |
0.6 |
1.59 |
post excision weight measurement |
0.0 |
|
103414 |
2824 |
| LH/Mav |
aorta weight to body weight ratio |
perindopril (0.4 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
aorta mass |
male |
119.0 days
| 8 |
12.5 |
mg/100g |
0.6 |
1.7 |
post excision weight measurement |
0.0 |
|
103415 |
2824 |
| LH/Mav |
aorta weight to body weight ratio |
perindopril (1.5 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
aorta mass |
male |
119.0 days
| 8 |
13.6 |
mg/100g |
0.5 |
1.41 |
post excision weight measurement |
0.0 |
|
103416 |
2824 |
| LH/Mav |
aorta weight to body weight ratio |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
aorta mass |
male |
112.0 days
| 11 |
13.5 |
mg/100g |
0.2 |
0.66 |
post excision weight measurement |
0.0 |
|
102772 |
2721 |
| LH/Mav |
aorta weight to body weight ratio |
controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
aorta mass |
male |
119.0 days
| 6 |
15.7 |
mg/100g |
0.8 |
1.96 |
post excision weight measurement |
0.0 |
|
103417 |
2824 |
| LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112.0 days
| 8 |
13.5 |
mg/100g |
0.5 |
1.41 |
post excision weight measurement |
0.0 |
|
102688 |
2703 |
| LH/Mav |
aorta weight to body weight ratio |
controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
aorta mass |
male |
119.0 days
| 7 |
15.8 |
mg/100g |
0.8 |
2.12 |
post excision weight measurement |
0.0 |
|
103418 |
2824 |
| LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112.0 days
| 9 |
12.3 |
mg/100g |
0.4 |
1.2 |
post excision weight measurement |
0.0 |
|
102689 |
2703 |